Non-Alcoholic Fatty Liver Disease (NAFLD) is an increasingly recognized as a major health concern linked with sedentary lifestyle and unhealthy dietary habits, that believed to affect >25% of adult world wide. Asia is a vast continent with much variability in economic development, lifestyle habits and genetic background. According to World meter data from 2021, Asia is home to 48 countries and 4.67 billion people. Recent data suggest that the prevalence of non-alcoholic fatty liver disease (NAFLD) in Asia has increased to 34%, which is as high as figures in Europe and North America.1 Although Asians appear to have less severe liver histology and better clinical outcomes, the epidemiology is rapidly changing with NAFLD-associated hepatocellular carcinoma (HCC) on the rise.2Hepatic manifestation of metabolic Syndrome & its strongly associated with dyslipidaemia, insulin resistance & obesity, these factors collectively Contribute to cardiovascular diseases, which are the leading Cause of morbidity & mortality in NAFLD patients contrary to hypolipidemia, NAFLD commonly presents with elevated Triglycerides & low HDL Cholesterol. The chronic low-grade Inflammation & Oxidative Stress associated with NAFLD further exacerbate vascular dysfunction & atherosclerosis early detection & management of lifestyle factors are essential in Preventing the progression of NAFLD and reducing Cardiovascular risk.

C. Nagesh is currently pursuing his Bachelor of Science in Cardiovascular Technology at Chaitanya Deemed to be University, India. He is in his third year of study with a strong academic focus on the cardiovascular system. He has actively participated in a national conference, showcasing his early commitment to professional development in the field. With growing interest in cardiovascular sciences, he aims to contribute to advancements in cardiac care and technology through further education and research.